Life Saving Drugs Program – Gaucher disease (type 1) – Guidelines

These guidelines contain the general, initial and ongoing eligibility requirements to access certain medications for Gaucher disease (type 1) under the Life Saving Drugs Program.

Cover page for the Life Saving Drugs Program – Gaucher disease (type 1) – Guidelines

These guidelines include:

  • General information about the Life Saving Drugs Program (LSDP)
  • Treatment of Gaucher disease through the LSDP
  • Drugs currently available for the treatment of Gaucher disease through the LSDP
  • Choice of treatment
  • Dosage
  • Home infusion
  • General, initial and ongoing eligibility requirements
  • LSDP funding conditions
  • Exclusion criteria.

Life Saving Drugs Program – Gaucher disease (type 1) – Guidelines

About this resource

Publication date:
Publication type:
Guideline
Language:
English

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.